Somewhat Favorable News Coverage Somewhat Unlikely to Impact Cooper Companies, Inc. (The) (COO) Share Price

News coverage about Cooper Companies, Inc. (The) (NYSE:COO) has trended somewhat positive this week, Accern Sentiment reports. Accern ranks the sentiment of media coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cooper Companies, Inc. (The) earned a news sentiment score of 0.25 on Accern’s scale. Accern also gave media coverage about the medical device company an impact score of 46.5411424142501 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

These are some of the headlines that may have impacted Accern Sentiment’s analysis:

Shares of Cooper Companies, Inc. (COO) traded up $1.29 during mid-day trading on Tuesday, reaching $239.94. 184,600 shares of the company traded hands, compared to its average volume of 424,267. The company has a quick ratio of 1.29, a current ratio of 2.51 and a debt-to-equity ratio of 0.38. The stock has a market cap of $11,680.00, a P/E ratio of 25.52, a price-to-earnings-growth ratio of 2.05 and a beta of 0.55. Cooper Companies, Inc. has a one year low of $158.73 and a one year high of $256.39.

Cooper Companies, Inc. (The) (NYSE:COO) last announced its quarterly earnings results on Thursday, August 31st. The medical device company reported $2.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.58 by $0.06. The firm had revenue of $556.00 million for the quarter, compared to the consensus estimate of $552.32 million. Cooper Companies, Inc. (The) had a net margin of 16.45% and a return on equity of 16.00%. The business’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter last year, the firm posted $2.30 EPS. analysts anticipate that Cooper Companies, Inc. will post 9.72 EPS for the current year.

Several research analysts recently issued reports on the stock. Zacks Investment Research upgraded shares of Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $257.00 price target for the company in a research note on Tuesday, November 14th. KeyCorp reiterated a “hold” rating on shares of Cooper Companies, Inc. (The) in a research note on Friday, October 20th. Robert W. Baird set a $273.00 price target on shares of Cooper Companies, Inc. (The) and gave the stock a “buy” rating in a research note on Monday, October 16th. BMO Capital Markets reissued a “buy” rating and set a $272.00 price objective on shares of Cooper Companies, Inc. (The) in a research report on Friday, October 13th. Finally, Jefferies Group LLC reissued a “buy” rating and set a $250.00 price objective on shares of Cooper Companies, Inc. (The) in a research report on Tuesday, September 12th. Six investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Cooper Companies, Inc. (The) has a consensus rating of “Buy” and a consensus target price of $260.22.

TRADEMARK VIOLATION WARNING: “Somewhat Favorable News Coverage Somewhat Unlikely to Impact Cooper Companies, Inc. (The) (COO) Share Price” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another site, it was illegally stolen and republished in violation of United States & international trademark and copyright laws. The original version of this news story can be viewed at

In other news, Director Gary S. Petersmeyer sold 3,977 shares of the firm’s stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $244.94, for a total transaction of $974,126.38. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 1.60% of the company’s stock.

About Cooper Companies, Inc. (The)

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Insider Buying and Selling by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with's FREE daily email newsletter.

Leave a Reply